Definitive Healthcare Corp. (Nasdaq: DH), an industry leader in
healthcare commercial intelligence, today announced that Carrie
Lazorchak has been named Chief Revenue Officer, effective November
1, 2023.
“I am thrilled to welcome Carrie Lazorchak to Definitive
Healthcare as our new Chief Revenue Officer,” said Robert
Musslewhite, Chief Executive Officer of Definitive Healthcare.
“Carrie is a fantastic fit for Definitive Healthcare. Her values
and her deep belief in the power of humble collaboration make her a
perfect match for our culture. Carrie brings a wealth of experience
selling Software as a Service to both enterprise accounts and small
and medium size businesses across a range of verticals. Her passion
for customer success is evident in everything she does, and I look
forward to working with her to continue to grow Definitive
Healthcare long into the future.”
Lazorchak joins Definitive Healthcare from SimilarWeb, a
publicly-traded digital data and analytics company, where she has
been the Chief Revenue Officer for the past five years. Prior to
SimilarWeb, Lazorchak worked at Nuance Communications, a leader in
speech recognition and artificial intelligence software, where she
led the worldwide sales and customer success teams for the
enterprise division and helped build and lead the sales team for
the mobile and embedded division during her 17-year tenure with the
company. Lazorchak has a B.A. in Communications and Marketing from
Salisbury State and an M.S. in Information and Telecommunication
Systems from The Johns Hopkins University.
“I’m very excited to join the Definitive Healthcare team,” said
Lazorchak. “The market for healthcare commercial intelligence is
still in the early innings, and companies selling into the
healthcare market need data, analytics, and expertise to succeed. I
look forward to working with the Definitive Healthcare sales
organization to grow our client base, expand our relationships with
clients, enhance the value that we deliver through our products and
services, and drive operational excellence.”
When Lazorchak joins Definitive Healthcare on November 1,
current Chief Revenue Officer Joe Mirisola will transition to
Senior Advisor before departing Definitive Healthcare at the end of
2023.
“I want to thank Joe for his contributions to Definitive
Healthcare over the past decade,” said Musslewhite. “Joe was the
first employee that Definitive Healthcare Founder Jason Krantz
hired, and Joe helped grow Definitive Healthcare from its first
dollar of revenue in 2011 to the $240 million business that it is
today. We wish him well as he takes a well-deserved break and
embarks on his next chapter.”
About Definitive Healthcare
At Definitive Healthcare, our passion is to transform data,
analytics and expertise into healthcare commercial intelligence. We
help clients uncover the right markets, opportunities and people,
so they can shape tomorrow’s healthcare industry. Our SaaS platform
creates new paths to commercial success in the healthcare market,
so companies can identify where to go next. Learn more
at definitivehc.com.
Forward-Looking
Statements
This press release includes forward-looking statements that
reflect our current views with respect to future events and
financial performance. Such statements are provided under the “safe
harbor” protection of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements include all statements that do
not relate solely to historical or current facts, and can generally
be identified by words or phrases written in the future tense
and/or preceded by words such as “likely,” “should,” “may,”
“anticipates,” “intends,” “plans,” “seeks,” “believes,”
“estimates,” “expects” or similar words or variations thereof, or
the negative thereof, references to future periods, or by the
inclusion of forecasts or projections, but these terms are not the
exclusive means of identifying such statements. Examples of
forward-looking statements include, but are not limited to,
statements we make regarding our outlook, financial guidance, the
market, industry and macroeconomic environment, our business,
growth strategies, product development efforts and future expenses,
customer growth and statements reflecting our expectations about
our ability to execute on our strategic plans, achieve future
growth and profitability and achieve our financial goals.
Forward-looking statements in this press release are based on
our current expectations and assumptions regarding our business,
the economy and other future conditions. Because forward-looking
statements relate to the future, by their nature, they are subject
to inherent uncertainties, risks and changes in circumstances that
are difficult to predict. As a result, our actual results may
differ materially from those contemplated by the forward-looking
statements. Important factors that could cause actual results to
differ materially from those in the forward-looking statements.
Factors or events that could cause our actual performance to differ
from these forward-looking statements may emerge from time to time,
and it is not possible for us to predict all of them. Should one or
more of these risks or uncertainties materialize, or should any of
our assumptions prove incorrect, our actual financial condition,
results of operations, future performance and business may vary in
material respects from the performance projected in these
forward-looking statements.
For additional discussion of factors that could impact our
operational and financial results, refer to our Quarterly Report on
Form 10-Q for the three months ended June 30, 2023, our 2022 Form
10-K/A and our Q1 2023 Form 10-Q/A, as well as our Current Reports
on Form 8-K and other subsequent SEC filings, which are or will be
available on the Investor Relations page of our website at
ir.definitivehc.com and on the SEC website at www.sec.gov.
All information in this press release speaks only as of the date
on which it is made. We undertake no obligation to publicly update
this information, whether as a result of new information, future
developments or otherwise, except as may be required by law.
Investor Relations Contact:Brian DenyeauICR for
Definitive Healthcarebrian.denyeau@icrinc.com646-277-1251
Media Contacts:Danielle
Johnsdjohns@definitivehc.com
Highwire PRdefinitivehealthcare@highwirepr.com
Definitive Healthcare (NASDAQ:DH)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Definitive Healthcare (NASDAQ:DH)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024